Just had a surgeon tell me he used the Covidien ultrasonic in a pig lab and that it was very nice. Didnt go into many details but said having no wires and no box was a serious plus. Does anyone know when Covidien's ultrasonic is going to launch or have any more information on it? If it's comparable and wireless, what do we have left in our bag or what are we going to add to make up for this? I ask because we are already losing marketshare to the new small ligasure and the G2 is nice but their just isn't a lot of surgeons doing open cases where it can be used. Tie all this in with reprocessing and it makes me wonder, how can EES survive without some type of new product? I am not talking about new Harmonic devices either as those are just to offset reprocessing.
How will EES Survive
- Thread starter Anonymous
- Start date
-
- Tags
- None
The layoffs that just happened are the answer to your question. There is nothing new to sustain growth.
we had the chance to buy the patent before they did. we walked away .
Just saw this. When were the layoffs? I used to work for the company but haven't kept in touch. Was it like the typical JNJ wipe out? That is why I left that company..I got really sick of the threat of it.
I heard Covidien had a wristed and wireless ultrasonic.
Yep, heard the same thing from one of my docs! Surgeon loves the idea of wireless. He also said the ergonomics is superior. Should be fun.
WTF? Thought we had one of our own coming too! New Credo: "Day late and a dollar short."
I'll believe it when I see it. The small jaw was suppose to have indication for ENT months ago and from what I hear, they are a year out on getting it. The G2 is taking more and more market share and will continue to do so! We still are the market leader for vessel sealing and will continue to be so!
G2 taking market share? Please. We are only growing by an average of 17% a year. Why would a Surgeon even think of leaving Impact to go to G2? You have technology that has been out for years and you can't get a foothold anywhere. Keep dreaming!!
Covidien always had an edge over EES from the surgeons point of view going way back to the days of Harmonic and Ligasure. They loved Ligasure and were lukewarm on Harmonic. Deservedly so. I sold the Harmonic but knew Ligasure was a much easier product to use and would have been the one that I would use.
Doesn't the word "reorganization" answer your question?
Aren't we also growing fixation at a crazy rate? How much longer will we all get to sell Securestrap?
Lots of questions, lots of uncertainty. EES has been a great place to be and there are a lot of folks that have been there for 12-15 years. Clearly there are some issues or half of the sales force wouldn't have gone to Intuitive. I think the messaging around reorganization is not clear, and leaves people with more stress, concern and I guess hope in some cases that they figure it out, and soon. I am glad they are looking for input on the change, but my question is aren't we paying folks the big bucks to make those calls. Throw 400K my way and I will figure something out 
Hang in there............
Hang in there............I am a full line, so can only speak from a sales person's perspective. I keep hearing that we need to change and it seems like everyone is agreeing with corporate. How can it change? So what if we are 97% to goal. We are still making a ton of money and that's not bad at all when the whole country is suffering! You would think we are on the verge of bankruptcy with all this transformation talk. We are already lean in the field with most reps covering very large geographies alone. Yes, reprocessing and innovation is an issue and that DOES need to change. Outside of that, I don't know how we can transform. There is not always an answer unfortunately. Times are different and although we may not be as profitable, we are still a strong company with solid earnings. To me, there is much more to lose by making a lot of changes than to leave things as they are and recognize the economy is in the shitter and when things do turn around we will reap the benefits.
I just think we need not to panic.
I just think we need not to panic.
Your point is well taken however you are in a world that is dominated by stock price and share holders. JNJ has a history of making moves like this although it appears like things are great and change is not needed.
JNJ always need to make it appear as though they are proactive and staying ahead of the business. Its all bullshit smoke and mirrors of course but that is the world of JNJ and sadly they run the Medical Device sector like the pharma sector.
Yes, I agree. However, don't you think this is a short term solution to prop up the stock price? A year down the road and beyond ees will be getting their asses handed to them by covidien. They think it's bad now? You Gotta pay to play! If ees want to continue to dominate the market, unfortunately more money and resources are needed...not less!
I believe you have to look at this from a short term or long term perspective. It's impossible to do both and you have pick one. I hope ees picks the latter. Once we become number 2 in the market it's going to be very difficult to recover and it will snowball out of control.
What flavor of the Company KoolAid are you drinking today? Can you send us some samples?
Just wait until Intuitive launches the stapler, then EES will really be in trouble!
If you can't beat 'em, join 'em.
Ethicon Endo-Surgery to Acquire SterilMed
Acquisition expands product portfolio and opportunities for delivering innovative and cost-effective solutions to healthcare customers
Cincinnati, OH (September 28, 2011) – Ethicon Endo-Surgery, Inc. (EES), a global leader in the development of innovative medical devices for minimally invasive and open surgical procedures, today announced a definitive agreement to acquire privately-held SterilMed, Inc. (SterilMed), a leader in the reprocessing and remanufacturing of medical devices in the United States. Financial terms of the agreement are not being disclosed.
SterilMed, based in Maple Grove, MN, offers products and services including medical device reprocessing, equipment repair, and pre-owned equipment sales that help healthcare providers lower their medical device and equipment costs, while reducing the amount of environmental waste they generate. The acquisition broadens EES’ portfolio and enables expansion in a rapidly growing market segment, while also bringing added scale, scope and experience to an already successful SterilMed team.
“The time is right for Ethicon Endo-Surgery and SterilMed to come together, given the rapid changes occurring in the U.S. healthcare system,” said Karen Licitra, Company Group Chairman and Worldwide Franchise Chairman for Ethicon Endo-Surgery. “Together, we can continue our focus on developing innovative surgical solutions, while providing healthcare facilities a wider range of flexible product options to save money, reduce medical waste, and maintain quality care for patients.”
SterilMed will be managed as part of the Ethicon Endo-Surgery franchise, but will continue to operate as a stand-alone company and retain the name SterilMed.
“This is an exciting opportunity for both our customers and our company,” said Brian Sullivan, SterilMed Chairman and CEO. “Becoming part of the Ethicon Endo-Surgery franchise, one of the largest and most respected medical device companies in the world, will have a positive impact on our business, while also expanding our product portfolio.”
The closing of the acquisition is conditioned on the expiration or termination of all applicable waiting periods pursuant to the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions.
Ethicon Endo-Surgery to Acquire SterilMed
Acquisition expands product portfolio and opportunities for delivering innovative and cost-effective solutions to healthcare customers
Cincinnati, OH (September 28, 2011) – Ethicon Endo-Surgery, Inc. (EES), a global leader in the development of innovative medical devices for minimally invasive and open surgical procedures, today announced a definitive agreement to acquire privately-held SterilMed, Inc. (SterilMed), a leader in the reprocessing and remanufacturing of medical devices in the United States. Financial terms of the agreement are not being disclosed.
SterilMed, based in Maple Grove, MN, offers products and services including medical device reprocessing, equipment repair, and pre-owned equipment sales that help healthcare providers lower their medical device and equipment costs, while reducing the amount of environmental waste they generate. The acquisition broadens EES’ portfolio and enables expansion in a rapidly growing market segment, while also bringing added scale, scope and experience to an already successful SterilMed team.
“The time is right for Ethicon Endo-Surgery and SterilMed to come together, given the rapid changes occurring in the U.S. healthcare system,” said Karen Licitra, Company Group Chairman and Worldwide Franchise Chairman for Ethicon Endo-Surgery. “Together, we can continue our focus on developing innovative surgical solutions, while providing healthcare facilities a wider range of flexible product options to save money, reduce medical waste, and maintain quality care for patients.”
SterilMed will be managed as part of the Ethicon Endo-Surgery franchise, but will continue to operate as a stand-alone company and retain the name SterilMed.
“This is an exciting opportunity for both our customers and our company,” said Brian Sullivan, SterilMed Chairman and CEO. “Becoming part of the Ethicon Endo-Surgery franchise, one of the largest and most respected medical device companies in the world, will have a positive impact on our business, while also expanding our product portfolio.”
The closing of the acquisition is conditioned on the expiration or termination of all applicable waiting periods pursuant to the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions.
I have been fighting reprocessing for so long, how does leadership expect me to go back to my cusomters and say sorry, I was wrong?! It will destroy my credibility with my cusotmer. Can't wait to see the reaction of my customers! I knew EES was going to have to make an acquisition to get out of the downer it is in, but this is not the one I was hoping for.